Article Text
Statistics from Altmetric.com
Neurology in Asia is different. The difference is due to three pairs of underlying factors: ethnic and genetic, geographical and environmental, social and cultural. These in turn affect the cause, manifestations, treatment, and outcome of neurological diseases—and so clinical neurology practice in Asia.
Multiple sclerosis (MS) is the best example of how ethnic and genetic factors determine the prevalence and manifestations of neurological disease in Asia. Almost all Asian countries have a low prevalence of MS—less than five per 100,000 population. The exceptions are those in west and central Asia, such as Israel, Kuwait, the Russians in Northern Kazakhstan and Turkmenistan, whose populations are “Caucasian”. The Parsis in India, who are of Persian descent, also have a high prevalence of MS. MS in Asia is also different from that of the West because a family history is rare, the female to male sex ratio is higher, visual involvement is more severe, the spinal cord is more severely affected, often with acute transverse myelitis and a long lesion on MRI and greater functional disability, the cerebellum is less often involved, oligoclonal bands are less frequent …
Read the full text or download the PDF:
Other content recommended for you
- Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia
- Burden of neurological diseases in Asia from 1990 to 2019: a systematic analysis using the Global Burden of Disease Study data
- VIRAL ENCEPHALITIS: CAUSES, DIFFERENTIAL DIAGNOSIS, AND MANAGEMENT
- Tackling Nipah virus: £2.36 million grant awarded to Pirbright to create vaccine
- Diagnosis and treatment of viral encephalitis
- Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response
- COVID-19–associated acute transverse myelitis: a rare entity
- Viral encephalitis: a clinician’s guide
- Neurocysticercosis: mimics and chameleons
- Late clinical and magnetic resonance imaging follow up of Nipah virus infection